FOSTER CITY, Calif. & SANTA MONICA, Calif., May 15, 2025--Gilead Sciences, Inc. (Nasdaq: GILD) will present more than 20 abstracts across both Gilead and Kite at the upcoming 2025 American Society ...

Stockley Park, UK – 19 April 2023 – Kite, a Gilead Company, will support eight data presentations, including updated findings in multiple indications across its portfolio of two CAR T-cell therapies ...

SANTA MONICA, Calif., June 01, 2025--Kite, a Gilead Company (Nasdaq: GILD), today announced real-world data evaluating the safety and effectiveness of Yescarta® (axicabtagene ciloleucel) for ...

Kite Pharma, Inc. (Nasdaq:KITE) today announced that new data will be presented from multiple studies related to its ... Oral Presentation on Novel T cell Manufacturing Process for KTE-C19 in ...

Mathematical comparisons of the engravings with documented kites revealed similarity scores — the diagram from Jordan was found to be most similar to a kite located 1.4 miles (2.3 kilometers ...

Gilead Sciences, Inc. (NASDAQ:GILD) plans to present over 20 research abstracts—spanning both Gilead and its cell therapy unit Kite—at two major medical conferences: the 2025 ASCO Annual ...

Gilead and Kite Announce Presentation of Transformative Data in 1L Metastatic Triple-Negative Breast Cancer, Updated Results in Multiple Myeloma and Early Data From Novel Investigational CAR T ...

Gilead and Kite Announce Presentation of Transformative Data in 1L Metastatic Triple-Negative Breast Cancer, Updated Results in Multiple Myeloma and Early Data From Novel Investigational CAR T ...

FOSTER CITY, Calif. & SANTA MONICA, Calif., May 15, 2025--Gilead Sciences, Inc. (Nasdaq: GILD) will present more than 20 abstracts across both Gilead and Kite at the upcoming 2025 American Society of ...

FOSTER CITY, Calif.& SANTA MONICA, Calif.---- Gilead Sciences, Inc. will present more than 20 abstracts across both Gilead and Kite at the upcoming 2025 American Society of Clinical Oncology ...